NCT00813865View on ClinicalTrials.gov

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 11, 2009

Primary Completion Date

May 1, 2012

Study Completion Date

May 1, 2012

Conditions
Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1
Interventions
DRUG

afegostat tartrate

Trial Locations (4)

30033

Decatur

33065

Coral Springs

02114

Boston

Unknown

London

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY

NCT00813865 - A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients | Biotech Hunter | Biotech Hunter